Dermatology

Spondyloarthritis

Questions discussed in this category

How do you manage injection site reactions in patients on subcutaneous biologics such as TNF inhibitors?

In what cases do you discontinue the medication?

2 Answers available

Do you use apremilast in combination with biologic DMARDs for psoriatic arthritis and/or psoriasis?

Are there ways to overcome barriers in insurance coverage of this combination of treatments?

2 Answers available

Would you consider using a JAK inhibitor in combination with an IL 23 inhibitor in cases of severe psoriasis, psoriatic arthritis, or axial spondyloarthritis that is refractory to multiple biologic DMARDs?

2 Answers available

What treatment options are available for patients with spondyloarthritis who develop biologic-induced psoriasis?

1 Answer available

Papers discussed in this category

Journal of psoriasis and psoriatic arthritis, 2019-04

TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management.

Front Pharmacol, 2019 Mar 26

Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders.

The Journal of rheumatology, 2012-01

Combination biologic treatment of refractory psoriasis and psoriatic arthritis.

JAAD Case Rep, 2019 Oct 10

Dual biologic therapy for recalcitrant psoriasis and psoriatic arthritis.

Current rheumatology reviews, 2019

Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis.

Am J Clin Dermatol, 2022 Jun 23

Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review.

Related Topics in Dermatology